EUVIMEDEUVIMED entdecken
Crossref

Toyaburgine, a Synthetic N -Biphenyl-Dihydroisoquinoline Inspired by Related N , C -Coupled Naphthylisoquinoline Alkaloids, with High In Vivo Efficacy in Preclinical Pancreatic Cancer Models

Suresh Awale iD, Juthamart Maneenet, Nguyen Duy Phan, Hung Hong Nguyen iD, Tsutomu Fujii iD, Heiko Ihmels iD, Denisa Soost, Nasir Tajuddeen, Doris Feineis, Gerhard Bringmann iD

ACS Chemical Biology · 2025

DOI: 10.1021/acschembio.4c00870 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Chemical Biology, 2025. Verfasst von Suresh Awale und 9 weiteren Autor:innen. Beteiligte Einrichtung: Natural Drug Discovery Laboratory, Institute of Natural Medicine, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Antineoplastic Agents, Alkaloids, Isoquinolines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Deutsche Forschungsgemeinschaft, Japan Society for the Promotion of Science, University of Toyama.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic cancer is a highly aggressive and lethal malignancy, with a 5-year survival rate below 10%. Traditional chemotherapy, including gemcitabine, has limited efficacy due to chemoresistance and a unique tumor microenvironment characterized by hypovascularity and nutrient deprivation. This study reports on the discovery of a new N-biphenyl-dihydroisoquinoline, named toyaburgine (4), inspired by naturally occurring N,C-coupled naphthylisoquinoline alkaloids. Developed through systematic structural optimization, toyaburgine is a potent anticancer agent, showing promise for pancreatic cancer treatment. It exhibits strong antiausterity activity with low nanomolar PC50 values, effectively inhibiting pancreatic cancer cell viability under nutrient-deprived conditions. In vitro, 4 causes significant morphological changes and cancer cell death in MIA PaCa-2 cells while also inhibiting cell migration and colony formation, which indicates its antimetastatic potential. Mechanistically, toyaburgine disrupts the PI3K/Akt/mTOR pathway, essential for pancreatic cancer cell survival in a stressful microenvironment, and inhibits MIA PaCa-2 spheroid formation. In vivo, toyaburgine, alone or combined with gemcitabine, shows effective tumor suppression in subcutaneous xenograft and clinically relevant orthotopic models, where it also reduces cachexia. These results highlight the potential of toyaburgine as a new therapeutic drug for pancreatic cancer. Its combination with gemcitabine presents a promising treatment approach by targeting both proliferating and gemcitabine-resistant cancer cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsAntineoplastic AgentsAlkaloidsIsoquinolinesBiphenyl CompoundsHumansAnimalsCell Line, TumorMiceCell ProliferationCell SurvivalCell MovementXenograft Model Antitumor AssaysMice, Nude

Substanzen

Antineoplastic AgentsAlkaloidsIsoquinolinesBiphenyl Compounds

Autor:innen und Institutionen

  • Natural Drug Discovery Laboratory, Institute of Natural Medicine, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.
  • Department of Surgery and Science, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan.
  • Department of Chemistry-Biology, and Center of Micro- and Nanochemistry and (Bio)Technology (Cμ), University of Siegen, Adolf-Reichwein-Straße 2, 57068 Siegen, Germany.
  • Department of Chemistry, Ahmadu Bello University, 810107 Zaria, Nigeria.
  • Institute of Organic Chemistry, University of Würzburg, Am Hubland, 97074 Würzburg, Germany.

ORCID-Profile: Suresh Awale, Hung Hong Nguyen, Tsutomu Fujii, Heiko Ihmels, Gerhard Bringmann

Förderung

  • Deutsche Forschungsgemeinschaft
  • Japan Society for the Promotion of Science
  • University of Toyama

Zitieren

APA

Awale, S., Maneenet, J., Phan, N. D., Nguyen, H. H., Fujii, T., Ihmels, H., Soost, D., Tajuddeen, N., Feineis, D., & Bringmann, G. (2025). Toyaburgine, a Synthetic N -Biphenyl-Dihydroisoquinoline Inspired by Related N , C -Coupled Naphthylisoquinoline Alkaloids, with High In Vivo Efficacy in Preclinical Pancreatic Cancer Models. ACS Chemical Biology. https://doi.org/10.1021/acschembio.4c00870

Vancouver

Awale S, Maneenet J, Phan ND, Nguyen HH, Fujii T, Ihmels H, et al. Toyaburgine, a Synthetic N -Biphenyl-Dihydroisoquinoline Inspired by Related N , C -Coupled Naphthylisoquinoline Alkaloids, with High In Vivo Efficacy in Preclinical Pancreatic Cancer Models. ACS Chemical Biology. 2025. doi:10.1021/acschembio.4c00870

BibTeX
@article{Awale2025,
  author = {Awale, Suresh and Maneenet, Juthamart and Phan, Nguyen Duy and Nguyen, Hung Hong and Fujii, Tsutomu and Ihmels, Heiko and Soost, Denisa and Tajuddeen, Nasir and Feineis, Doris and Bringmann, Gerhard},
  title = {Toyaburgine, a Synthetic N -Biphenyl-Dihydroisoquinoline Inspired by Related N , C -Coupled Naphthylisoquinoline Alkaloids, with High In Vivo Efficacy in Preclinical Pancreatic Cancer Models},
  journal = {ACS Chemical Biology},
  year = {2025},
  doi = {10.1021/acschembio.4c00870}
}
Kostenlos starten →